Mammary Cell News Volume 15.44 | Nov 9 2023

    0
    7








    2023-11-09 | MCN 15.44


    Mammary Cell News by STEMCELL Technologies
    Vol. 15.44 – 9 November, 2023
    TOP STORY

    Reconstruction of Dynamic Mammary Mini Gland In Vitro for Normal Physiology and Oncogenesis

    Researchers described the development of a long-term adult stem cell-derived mammary mini gland culture system that supports robust three-dimensional outgrowths.
    [Nature Methods]

    Abstract
    A person presenting slides at a scientific conference
    PUBLICATIONSRanked by the impact factor of the journal

    Metabolic Dependencies of Metastasis-Initiating Cells in Female Breast Cancer

    The authors examined the metabolic adaptations of metastasis-initiating cells in female breast cancer and how those shaped their metastatic phenotype.
    [Nature Communications]

    Full Article

    Interactions between BRD4S, LOXL2, and MED1 Drive Cell Cycle Transcription in Triple-Negative Breast Cancer

    Investigators demonstrated that the simultaneous inhibition of lysyl oxidase-like 2 (LOXL2) and bromodomain-containing protein 4 (BRD4) synergistically limited TNBC proliferation in vitro and in vivo.
    [EMBO Molecular Medicine]

    Full ArticleGraphical Abstract

    Suppression of TNBC Metastasis by Doxazosin, a Novel Dual Inhibitor of C-MET/EGFR

    The effect of doxazosin on TNBC cell lines in vitro was evaluated in terms of cell viability, apoptosis, c-MET/EGFR signaling pathway, molecular docking studies, and impact on cancer stem cell-like properties.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    Targeting PRMT1-Mediated SRSF1 Methylation to Suppress Oncogenic Exon Inclusion Events and Breast Tumorigenesis

    In breast tumors, PRMT1 overexpression was associated with increased SRSF1 arginine methylation and aberrant exon inclusion, which were critical for breast cancer cell growth.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Combined In Vitro/In Vivo Genome-Wide CRISPR Screens in Triple Negative Breast Cancer Identify Cancer Stemness Regulators in Paclitaxel Resistance

    Scientists reported a combined in vitro/in vivo genome-wide CRISPR synthetic lethality screening approach in a relevant TNBC cell line model to identify several targets responsible for paclitaxel resistance.
    [Oncogenesis]

    Full Article

    Exosomal circRNA RHOT1 Promotes Breast Cancer Progression by Targeting miR-204-5p/ PRMT5 Axis

    Circular RNA RHOT1 exhibited significantly high expression in exosomes derived from the serum of breast cancer patients and breast cancer cell lines, which suggested its potential diagnostic value.
    [Cancer Cell International]

    Full Article

    Thrombin Induces Ferroptosis in Triple-Negative Breast Cancer through the cPLA2α/ACSL4 Signaling Pathway

    Researchers found that F2, the gene encoding thrombin, was strongly upregulated in breast cancer compared with normal samples and that lower F2 levels were associated with poorer prognosis in breast cancer patients.
    [Translational Oncology]

    Full ArticleGraphical Abstract

    Degradation of AZGP1 Suppresses the Progression of Breast Cancer Cells via TRIM25

    Scientists analyzed the online datasets and found that Alpha-2-glycoprotein 1, zinc-binding (AZGP1) was highly expressed in breast cancer tissues and its expression was negatively correlated with the survival of breast cancer patients.
    [Environmental Toxicology]

    Abstract

    Anticancer and Anti-Metastasis Activity of 1,25 Dihydroxycholecalciferols and Genistein in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines

    Researchers studied the impact of 1,25 dihydroxycholecalciferols (1,25(OH)2D3) and genistein on the proliferation, progression, and metastasis of MCF-7 and MDA-MB-231 cells and investigated whether there was a synergistic effect between genistein and 1,25(OH)2D3.
    [Heliyon]

    Full ArticleGraphical Abstract
    Guide to everything you need to know about cell separation.
    REVIEWS

    Exploring the Therapeutic Potential of ADC Combination for Triple-Negative Breast Cancer

    Scientists described the current utilization of antibody–drug conjugates (ADCs) and discussed the prospects of ADC combination therapy for TNBC.
    [Cellular and Molecular Life Sciences]

    Abstract

    Molecular Targets and Therapeutic Strategies for Triple-Negative Breast Cancer

    The authors emphasize the most recent research on nutraceuticals, medication repositioning, and novel therapeutic strategies for the treatment of TNBC.
    [Molecular Biology Reports]

    Abstract
    INDUSTRY AND POLICY NEWS

    Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer

    Immutep Limited announced the open-label safety lead-in of its integrated AIPAC-003 Phase II/III trial evaluating for the very first time 90mg of eftilagimod alpha in combination with paclitaxel has been completed with no safety or tolerability issues.
    [Immutep Limited]

    Press Release

    ISSCR and Cell Press Renew Publishing Agreement for Stem Cell Reports

    The International Society for Stem Cell Research (ISSCR) and publisher Cell Press announced the extension of their partnership to publish the ISSCR’s open-access, peer-reviewed journal, Stem Cell Reports.
    [The International Society for Stem Cell Research]

    Press Release
    FEATURED EVENT

    Cell & Gene Therapy Manufacturing & Commercialization Europe

    December 4 – 7, 2023
    Dublin, Ireland

    > See All Events

    JOB OPPORTUNITIES

    Scientist Positions – Pharmaceutical Sciences

    China Pharmaceutical University – Nanjing, Jiangsu, China

    Staff Scientist – Translational Sciences

    Baylor College of Medicine – Houston, Texas, United States

    Clinical Research Associate – Breast

    Cedars-Sinai – Los Angeles, California, United States

    Postdoctoral Associate – Breast Cancer Metastases

    Baylor College of Medicine – Houston, Texas, United States

    PhD Positions – Cancer Mechanobiology

    University of Galway – Galway, Ireland

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Logo for the social media website X